We are live on ! Find out more
FFVM

Founders Fund VI Management Portfolio holdings

AUM $45.8K
1-Year Est. Return 58.63%
This Fund
S&P 500
This Quarter Est. Return
+12.88%
1 Year Est. Return
-58.63%
3 Year Est. Return
-80.39%
5 Year Est. Return
10 Year Est. Return
AUM
$72.5K
AUM Growth
+$7.61K
Cap. Flow
+$11.3K
Cap. Flow %
15.57%
Top 10 Hldgs %
100%
Holding
2
New
1
Increased
Reduced
Closed
1

Top Buys

Rank Stock Value
1
RFL icon
Rafael Holdings
RFL
+$76.2K

Top Sells

Rank Stock Value
1
CYTH
Cyclo Therapeutics, Inc. Common Stock
CYTH
+$64.9K

Sector Composition

Rank Sector Weight
1 Real Estate 100%
2 Healthcare 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RFL icon
1
Rafael Holdings
RFL
$111M
$72.5K 100%
+39,327
New +$76.2K
CYTH
2
DELISTED
Cyclo Therapeutics, Inc. Common Stock
CYTH
-110,023
Closed -$64.9K

Similar funds

Founders Fund VI Management's Q1 2025 Portfolio in Review

As of Q1 2025, Founders Fund VI Management held 2 positions worth $72.5K, up 12% from $64.9K the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Founders Fund VI Management deployed $11.3K of net new capital in Q1 2025, opening 1 new position. Its largest new stake was Rafael Holdings: 39,327 shares worth $72.5K.

By sector, the portfolio is most concentrated in Real Estate at 100% of assets, followed by Healthcare.

On the sell side, the most notable exit was Cyclo Therapeutics, Inc. Common Stock, an estimated $64.9K sold.

  • Founders Fund VI Management's largest Q1 2025 buy was Rafael Holdings: 39,327 shares worth $72.5K.
  • Founders Fund VI Management fully exited Cyclo Therapeutics, Inc. Common Stock in Q1 2025, selling an estimated $64.9K.
  • Founders Fund VI Management's ten largest holdings make up 100% of its $72.5K portfolio in Q1 2025.
  • Founders Fund VI Management opened 1 new position and closed 1 in Q1 2025.
  • Founders Fund VI Management's portfolio value rose 12% quarter-over-quarter to $72.5K.

Based on Founders Fund VI Management's 13F filing for Q1 2025, filed 15 May 2025.